Martel, F <br/><br/>
Uptake of 1-methyl-4-phenylpyridinium (MPP+) by the JAR human placental choriocarcinoma cell line: comparison with 5-hydroxytryptamine.  [electronic resource] 

 -  Placenta  Apr 2003 
 - 361-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0143-4004 
<br/><br/><label>Standard No.: </label>10.1053/plac.2002.0917  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenylpyridinium--metabolism<br/>Carrier Proteins--metabolism<br/>Cell Line, Tumor<br/>Choriocarcinoma--metabolism<br/>Desipramine--pharmacology<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fluoxetine--pharmacology<br/>Humans<br/>Membrane Glycoproteins--metabolism<br/>Membrane Transport Proteins<br/>Nerve Tissue Proteins<br/>Placenta--drug effects<br/>Quinolinium Compounds--pharmacology<br/>Serotonin--metabolism<br/>Serotonin Plasma Membrane Transport Proteins<br/>Uterine Neoplasms--metabolism